Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders

2024CureusJournalOpen access

10.7759/cureus.72080 Full text19 citations

Authors

12 authors across 9 institutions in 5 countries.

John OlukorodeFirst author
- Babcock University (NG)
as printed: John O Olukorode
Dolapo A Orimoloye
- University of Lagos (NG)
Nwachukwu O Nwachukwu
Chidera N Onwuzo
- Lagos University Teaching Hospital (NG)
- Lagos State Health Service Commission (NG)
Praise O. Oloyede
- Babcock University (NG)
as printed: Praise O Oloyede
Temiloluwa Fayemi
- Babcock University (NG)
Oluwatobi S Odunaike
- Babcock University (NG)
Petra S Ayobami-Ojo
Nwachi Divine
- Babcock University (NG)
Demilade J Alo
- Babcock University (NG)
Demilade J Alo
- Babcock University (NG)
Chukwurah U AlexSenior author

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

Diabetes Treatment and Managementlevel 3 · 1.00
Pharmacology and Obesity Treatmentlevel 3 · 1.00
Diabetes Management and Researchlevel 3 · 1.00

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 9, 2026
2024 · Cureus · 19 citations
https://openalex.org/W4403659587

Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders · Sankore